Evidence map›Paper›PMID 37903605›Full record

ArticleBMJ open2023

Associations between spirometric impairments and microvascular complications in type 2 diabetes: a cross-sectional study.

Charles F Hayfron-Benjamin, Charles Agyemang, Bert-Jan H van den Born, Albert G B Amoah, Kwesi Nyan Amissah-Arthur, Latif Musah, Benjamin Abaidoo, Pelagia Awula, Henry Wedoi Awuviri, Joseph Agyapong Abbey and 5 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMJ open, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 3 countries.

Charles F Hayfron-BenjaminRespiratory Medicine, Vascular Medicine, and Public Health, Amsterdam UMC Locatie AMC, Amsterdam, The Netherlands charlesfhb1@gmail.com.ORCID 0000-0003-0175-0340
Charles AgyemangDepartment of Public Health, Amsterdam UMC Locatie AMC, Amsterdam, The Netherlands.
Bert-Jan H van den BornDepartment of Internal and Vascular Medicine, Amsterdam UMC Locatie AMC, Amsterdam, The Netherlands.ORCID 0000-0003-0943-4393
Albert G B AmoahDepartment of Medicine and Therapeutics, University of Ghana Medical School, Accra, Ghana.
Kwesi Nyan Amissah-ArthurDepartment of Surgery, University of Ghana Medical School, Accra, Ghana.
Latif MusahDepartment of Physiology, University of Ghana Medical School, Accra, Ghana.
Benjamin AbaidooDepartment of Surgery, University of Ghana Medical School, Accra, Ghana.
Pelagia AwulaDepartment of Physiology, University of Ghana Medical School, Accra, Ghana.
Henry Wedoi AwuviriDepartment of Physiology, University of Ghana Medical School, Accra, Ghana.
Joseph Agyapong AbbeyDepartment of Physiology, University of Ghana Medical School, Accra, Ghana.
Deladem A FummeyDepartment of Physiology, University of Ghana Medical School, Accra, Ghana.
Joana N AckamDepartment of Medicine, Family Health Medical School, Accra, Ghana.
Gloria Odom AsanteSchool of Nursing, University of Ghana, Legon, Ghana.
Simone HashimotoDepartment of Respiratory Medicine, Amsterdam UMC Locatie AMC, Amsterdam, The Netherlands.
Anke H Maitland-van der ZeeDepartment of Respiratory Medicine, Amsterdam UMC Locatie AMC, Amsterdam, The Netherlands.
University of Ghana · GHEmma Kinderziekenhuis · NLGGD Amsterdam · NLGhana Health Service · GHJohns Hopkins University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveEvidence shows that the conventional cardiometabolic risk factors do not fully explain the burden of microvascular complications in type 2 diabetes (T2D). One potential factor is the impact of pulmonary dysfunction on systemic microvascular injury. We assessed the associations between spirometric impairments and systemic microvascular complications in T2D.

designCross-sectional study.

settingNational Diabetes Management and Research Centre in Ghana.

participantsThe study included 464 Ghanaians aged ≥35 years with established diagnosis of T2D without primary myocardial disease or previous/current heart failure. Participants were excluded if they had primary lung disease including asthma or chronic obstructive pulmonary disease. PRIMARY AND SECONDARY OUTCOME MEASURES: The associations of spirometric measures (forced expiratory volume in 1 s (FEV

resultsIn age and sex-adjusted models, lower Z-score FEV

conclusionOur study shows positive but varying strengths of associations between pulmonary dysfunction and microvascular complications in different circulations. Future studies could explore the mechanisms linking pulmonary dysfunction to microvascular complications in T2D.

Indexed as

Diabetes Mellitus, Type 2Retinal DiseasesCross-Sectional StudiesGhanaHumansLungdiabetic nephropathy & vascular diseasediabetic neuropathydiabetic retinopathypulmonary disease, chronic obstructive

Identifiers

PMID37903605
PMCPMC10619106
OpenAlexW4388018881

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.